Mon, Jul 28, 2014, 12:20 AM EDT - U.S. Markets open in 9 hrs 10 mins


% | $
Click the to save as a favorite.

Sunshine Heart Inc. Message Board

  • swing_trader37 swing_trader37 Apr 17, 2013 11:04 PM Flag

    Wait until they announce the fully implantable version of C-Pulse

    They are currently working on it and when it's completed the stock price will soar IMO. Although I think Medtronic will acquire them before then for a huge premium over the current stock price. Again IMO.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • the fully implantable device will happen. However, it's not going to be part of the study and filing of NDA. Otherwise you're talking a considerable delay. It would happen after the device is approved. Anyway, the device is a whole lot less invasive than an LVAD as it stands

      Sentiment: Strong Buy

    • Stop pumping the stock, i will call you OUT.. there will be no run-up, buyout, etc until the product is approved, which is 3 to 4 years down the line. .. no company is going to purchase SSH until... any pumping, i will call out..

      Sentiment: Hold

    • Not sure what you are talking about, or your just the run of the mill 'pumper n dumper' which seems to be coming out lately, but if a new product is going to be implemented, it has to go through the same process as C-Pulse is doing right now, so if this new product exist, it will take another 5-7 years to get it to market, so please pump somewhere else..

      Sentiment: Hold

      • 2 Replies to johndrew101
      • johndrew
        You should check with the company.
        Fully implantable is an upgrade of the existing C-Pulse device not a new device.
        Not 5 to 7 years to market.
        As far as I know they just have to do a small study to prove its safe.
        The hope was to implant one this year.

      • Going to market in Europe NOW - already approved in Europe.
        Which market are you talking about???? If US 5-7 years is extreme outside - may even have an approval given during the trial (eg at mid-point 140 patients) if results reflect the feasibility trial and patient benefit is so startingly obvious

5.10-0.08(-1.53%)Jul 25 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.